IL17A and inflammatory bowel disease: Furthermore, an inherently increased co-aggregation of various IMIDs such as CD, UC, psoriasis and psoriatic arthritis could contribute to an increased number of IBD incident cases in the reviewed anti-IL-17/IL-17R studies [4, 5, 36]